103 related articles for article (PubMed ID: 35459373)
1. Inhaled glucocorticoids in treatment of covid-19.
Sova M; Zela O
Vnitr Lek; 2021; 67(6):328-329. PubMed ID: 35459373
[TBL] [Abstract][Full Text] [Related]
2. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.
Ramakrishnan S; Nicolau DV; Langford B; Mahdi M; Jeffers H; Mwasuku C; Krassowska K; Fox R; Binnian I; Glover V; Bright S; Butler C; Cane JL; Halner A; Matthews PC; Donnelly LE; Simpson JL; Baker JR; Fadai NT; Peterson S; Bengtsson T; Barnes PJ; Russell REK; Bafadhel M
Lancet Respir Med; 2021 Jul; 9(7):763-772. PubMed ID: 33844996
[TBL] [Abstract][Full Text] [Related]
3. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
Montero F; Martínez-Barrio J; Serrano-Benavente B; González T; Rivera J; Molina Collada J; Castrejón I; Álvaro-Gracia J
Rheumatol Int; 2020 Oct; 40(10):1593-1598. PubMed ID: 32794113
[TBL] [Abstract][Full Text] [Related]
5. Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis.
Baker JR; Mahdi M; Nicolau DV; Ramakrishnan S; Barnes PJ; Simpson JL; Cass SP; Russell REK; Donnelly LE; Bafadhel M
Lancet Respir Med; 2022 Jun; 10(6):545-556. PubMed ID: 35397798
[TBL] [Abstract][Full Text] [Related]
6. Response to Glucocorticoid Therapy in Patients with Mild to Moderate Coronavirus Disease 2019 at a Japanese Care Facility.
Kikuchi A; Arita R; Ono R; Tadano Y; Saito N; Akaishi T; Kanno T; Osawa M; Takayama S; Abe M; Onodera K; Ishii T
Tohoku J Exp Med; 2022 Jun; 257(2):97-106. PubMed ID: 35387909
[TBL] [Abstract][Full Text] [Related]
7. Management and outcomes of patients hospitalized with severe COVID-19 at a tertiary care center in midwestern United States.
Gupta S; Kaushik A; Gupta J
Monaldi Arch Chest Dis; 2020 Oct; 90(4):. PubMed ID: 33059413
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Associations Between Glucocorticoids Treatment and Mortality in COVID-19 Patients and SARS Patients: A Systematic Review and Meta-Analysis.
Li J; Liao X; Zhou Y; Wang L; Yang H; Zhang W; Zhang Z; Kang Y
Shock; 2021 Aug; 56(2):215-228. PubMed ID: 33555845
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
11. New Insights on Effects of Glucocorticoids in Patients With SARS-CoV-2 Infection.
Shacham EC; Ishay A
Endocr Pract; 2022 Oct; 28(10):1100-1106. PubMed ID: 35870803
[TBL] [Abstract][Full Text] [Related]
12. Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial.
Dalili N; Kashefizadeh A; Nafar M; Poorrezagholi F; Firouzan A; Samadian F; Samavat S; Ziaie S; Fatemizadeh S
Trials; 2020 Jun; 21(1):489. PubMed ID: 32503620
[TBL] [Abstract][Full Text] [Related]
13. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
Panovska-Stavridis I; Ridova N; Stojanoska T; Demiri I; Stevanovic M; Stojanovska S; Ristevska T; Dimkovski A; Filipce V; Dimovski A; Grozdanova A
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):5-18. PubMed ID: 33894123
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on glucocorticoid treatment for COVID-19: a systematic review.
Cordeiro LP; Linhares EONN; Nogueira FGO; Moreira-Silva D; Medeiros-Lima DJM
Pharmacol Rep; 2021 Jun; 73(3):728-735. PubMed ID: 33666864
[TBL] [Abstract][Full Text] [Related]
15. Are the steroids a blanket solution for COVID-19? A systematic review and meta-analysis.
Sarkar S; Khanna P; Soni KD
J Med Virol; 2021 Mar; 93(3):1538-1547. PubMed ID: 32881007
[TBL] [Abstract][Full Text] [Related]
16. The Role of Glucocorticoids in the Management of COVID-19.
Alexaki VI; Henneicke H
Horm Metab Res; 2021 Jan; 53(1):9-15. PubMed ID: 33207372
[TBL] [Abstract][Full Text] [Related]
17. Thyroid Function, Inflammatory Response, and Glucocorticoids in COVID-19.
Świątkowska-Stodulska R; Berlińska A; Puchalska-Reglińska E
Front Endocrinol (Lausanne); 2022; 13():939842. PubMed ID: 35966079
[TBL] [Abstract][Full Text] [Related]
18. Is dexamethasone an effective treatment for severe COVID-19 patients: Journal Club review.
Chan K; Sharif S; Rochwerg B
CJEM; 2021 Mar; 23(2):159-161. PubMed ID: 33534117
[No Abstract] [Full Text] [Related]
19. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
[TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management.
Mehta P; Gasparyan AY; Zimba O; Kitas GD
Clin Rheumatol; 2022 Sep; 41(9):2893-2910. PubMed ID: 35639259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
